Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA

References

• World Malaria Report WHO.. 2011;
   Google Scholar
• Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012; 379:413 - 31; http://dx.doi.org/10.1016/S0140-6736(12)60034-8; PMID: 22305225
   PubMed Web of Science ®Google Scholar
• Agnandji ST, Lell B, Soulanoudjingar SS, Fernandes JF, Abossolo BP, Conzelmann C, et al, RTS,S Clinical Trials Partnership. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med 2011; 365:1863 - 75; http://dx.doi.org/10.1056/NEJMoa1102287; PMID: 22007715
   PubMed Web of Science ®Google Scholar
• Moorthy VS, Ballou WR. Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data. Malar J 2009; 8:312; http://dx.doi.org/10.1186/1475-2875-8-312; PMID: 20042088
   PubMed Web of Science ®Google Scholar
• Clyde DF. Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am J Trop Med Hyg 1975; 24:397 - 401; PMID: 808142
   PubMed Web of Science ®Google Scholar
• Rieckmann KH, Carson PE, Beaudoin RL, Cassells JS, Sell KW. Letter: Sporozoite induced immunity in man against an Ethiopian strain of Plasmodium falciparum. Trans R Soc Trop Med Hyg 1974; 68:258 - 9; http://dx.doi.org/10.1016/0035-9203(74)90129-1; PMID: 4608063
   PubMed Web of Science ®Google Scholar
• Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002; 185:1155 - 64; http://dx.doi.org/10.1086/339409; PMID: 11930326
   PubMed Web of Science ®Google Scholar
• Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 2009; 361:468 - 77; http://dx.doi.org/10.1056/NEJMoa0805832; PMID: 19641203
   PubMed Web of Science ®Google Scholar
• Roestenberg M, Teirlinck AC, McCall MB, Teelen K, Makamdop KN, Wiersma J, et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 2011; 377:1770 - 6; http://dx.doi.org/10.1016/S0140-6736(11)60360-7; PMID: 21514658
   PubMed Web of Science ®Google Scholar
• Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, Laurens MB, et al. Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity. Science 2011; 334:475 - 80; http://dx.doi.org/10.1126/science.1211548; PMID: 21903775
   PubMed Web of Science ®Google Scholar
• Hoffman SL, Weiss W, Mellouk S, Sedegah M. Irradiated sporozoite vaccine induces cytotoxic T lymphocytes that recognize malaria antigens on the surface of infected hepatocytes. Immunol Lett 1990; 25:33 - 8; http://dx.doi.org/10.1016/0165-2478(90)90087-7; PMID: 2283160
   PubMed Web of Science ®Google Scholar
• Weiss WR, Mellouk S, Houghten RA, Sedegah M, Kumar S, Good MF, et al. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J Exp Med 1990; 171:763 - 73; http://dx.doi.org/10.1084/jem.171.3.763; PMID: 1689762
   PubMed Web of Science ®Google Scholar
• Hoffman SL, Sedegah M, Hedstrom RC. Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine. Vaccine 1994; 12:1529 - 33; http://dx.doi.org/10.1016/0264-410X(94)90078-7; PMID: 7879419
   PubMed Web of Science ®Google Scholar
• Sedegah M, Hedstrom R, Hobart P, Hoffman SL. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci USA 1994; 91:9866 - 70; http://dx.doi.org/10.1073/pnas.91.21.9866; PMID: 7937907
   PubMed Web of Science ®Google Scholar
• Sedegah M, Jones TR, Kaur M, Hedstrom R, Hobart P, Tine JA, et al. Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine. Proc Natl Acad Sci USA 1998; 95:7648 - 53; http://dx.doi.org/10.1073/pnas.95.13.7648; PMID: 9636204
   PubMed Web of Science ®Google Scholar
• Rogers WO, Weiss WR, Kumar A, Aguiar JC, Tine JA, Gwadz R, et al. Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen. Infect Immun 2002; 70:4329 - 35; http://dx.doi.org/10.1128/IAI.70.8.4329-4335.2002; PMID: 12117942
   PubMed Web of Science ®Google Scholar
• Dunachie SJ, Walther M, Epstein JE, Keating S, Berthoud T, Andrews L, et al. A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge. Infect Immun 2006; 74:5933 - 42; http://dx.doi.org/10.1128/IAI.00590-06; PMID: 16988273
   PubMed Web of Science ®Google Scholar
• Webster DP, Dunachie S, Vuola JM, Berthoud T, Keating S, Laidlaw SM, et al. Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara. Proc Natl Acad Sci USA 2005; 102:4836 - 41; http://dx.doi.org/10.1073/pnas.0406381102; PMID: 15781866
   PubMed Web of Science ®Google Scholar
• Sedegah M, Tamminga C, McGrath S, House B, Ganeshan H, Lejano J, et al. Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adults. PLoS ONE 2011; 6:e24586; http://dx.doi.org/10.1371/journal.pone.0024586; PMID: 22003383
   PubMed Web of Science ®Google Scholar
• Tamminga C, Sedegah M, Regis D, Chuang I, Epstein JE, Spring M, et al. Adenovirus-5-vectored P. falciparum vaccine expressing CSP and AMA1. Part B: safety, immunogenicity and protective efficacy of the CSP component. PLoS ONE 2011; 6:e25868; http://dx.doi.org/10.1371/journal.pone.0025868; PMID: 22003411
   PubMed Web of Science ®Google Scholar
• Reyes-Sandoval A, Sridhar S, Berthoud T, Moore AC, Harty JT, Gilbert SC, et al. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei. Eur J Immunol 2008; 38:732 - 41; http://dx.doi.org/10.1002/eji.200737672; PMID: 18266272
   PubMed Web of Science ®Google Scholar
• Reyes-Sandoval A, Berthoud T, Alder N, Siani L, Gilbert SC, Nicosia A, et al. Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses. Infect Immun 2010; 78:145 - 53; http://dx.doi.org/10.1128/IAI.00740-09; PMID: 19858306
   PubMed Web of Science ®Google Scholar
• Narum DL, Thomas AW. Differential localization of full-length and processed forms of PF83/AMA-1 an apical membrane antigen of Plasmodium falciparum merozoites. Mol Biochem Parasitol 1994; 67:59 - 68; http://dx.doi.org/10.1016/0166-6851(94)90096-5; PMID: 7838184
   PubMed Web of Science ®Google Scholar
• Robson KJ, Hall JR, Jennings MW, Harris TJ, Marsh K, Newbold CI, et al. A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature 1988; 335:79 - 82; http://dx.doi.org/10.1038/335079a0; PMID: 3045563
   PubMed Web of Science ®Google Scholar
• Rogers WO, Malik A, Mellouk S, Nakamura K, Rogers MD, Szarfman A, et al. Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc Natl Acad Sci USA 1992; 89:9176 - 80; http://dx.doi.org/10.1073/pnas.89.19.9176; PMID: 1409621
   PubMed Web of Science ®Google Scholar
• Doolan DL, Hoffman SL. DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation. Int J Parasitol 2001; 31:753 - 62; http://dx.doi.org/10.1016/S0020-7519(01)00184-9; PMID: 11403765
   PubMed Web of Science ®Google Scholar
• Kumar S, Epstein JE, Richie TL, Nkrumah FK, Soisson L, Carucci DJ, et al. A multilateral effort to develop DNA vaccines against falciparum malaria. Trends Parasitol 2002; 18:129 - 35; http://dx.doi.org/10.1016/S1471-4922(01)02207-3; PMID: 11854091
   PubMed Web of Science ®Google Scholar
• Le TP, Coonan KM, Hedstrom RC, Charoenvit Y, Sedegah M, Epstein JE, et al. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers. Vaccine 2000; 18:1893 - 901; http://dx.doi.org/10.1016/S0264-410X(99)00407-7; PMID: 10699338
   PubMed Web of Science ®Google Scholar
• Epstein JE, Gorak EJ, Charoenvit Y, Wang R, Freydberg N, Osinowo O, et al. Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes. Hum Gene Ther 2002; 13:1551 - 60; http://dx.doi.org/10.1089/10430340260201644; PMID: 12228010
   PubMed Web of Science ®Google Scholar
• Wang R, Doolan DL, Le TP, Hedstrom RC, Coonan KM, Charoenvit Y, et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 1998; 282:476 - 80; http://dx.doi.org/10.1126/science.282.5388.476; PMID: 9774275
   PubMed Web of Science ®Google Scholar
• Wang R, Richie TL, Baraceros MF, Rahardjo N, Gay T, Banania JG, et al. Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites. Infect Immun 2005; 73:2863 - 72; http://dx.doi.org/10.1128/IAI.73.5.2863-2872.2005; PMID: 15845492
   PubMed Web of Science ®Google Scholar
• Nussenzweig V, Nussenzweig RS. Circumsporozoite proteins of malaria parasites. Cell 1985; 42:401 - 3; http://dx.doi.org/10.1016/0092-8674(85)90093-5; PMID: 2411417
   PubMed Web of Science ®Google Scholar
• Doolan DL, Hedstrom RC, Rogers WO, Charoenvit Y, Rogers M, de la Vega P, et al. Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. J Biol Chem 1996; 271:17861 - 8; http://dx.doi.org/10.1074/jbc.271.30.17861; PMID: 8663412
   PubMed Web of Science ®Google Scholar
• Zhu J, Hollingdale MR. Structure of Plasmodium falciparum liver stage antigen-1. Mol Biochem Parasitol 1991; 48:223 - 6; http://dx.doi.org/10.1016/0166-6851(91)90117-O; PMID: 1840628
   PubMed Web of Science ®Google Scholar
• Prieur E, Druilhe P. The malaria candidate vaccine liver stage antigen-3 is highly conserved in Plasmodium falciparum isolates from diverse geographical areas. Malar J 2009; 8:247; http://dx.doi.org/10.1186/1475-2875-8-247; PMID: 19874576
   PubMed Web of Science ®Google Scholar
• Weiss WR, Ishii KJ, Hedstrom RC, Sedegah M, Ichino M, Barnhart K, et al. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J Immunol 1998; 161:2325 - 32; PMID: 9725227
   PubMed Web of Science ®Google Scholar
• Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008; 8:533 - 44; http://dx.doi.org/10.1038/nri2356; PMID: 18551128
   PubMed Web of Science ®Google Scholar
• Mirza S, Walker A, Chen J, Murphy JM, Young IG. The Ig-like domain of human GM-CSF receptor alpha plays a critical role in cytokine binding and receptor activation. Biochem J 2010; 426:307 - 17; http://dx.doi.org/10.1042/BJ20091745; PMID: 20078425
   PubMed Web of Science ®Google Scholar
• Parker SE, Monteith D, Horton H, Hof R, Hernandez P, Vilalta A, et al. Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine. Gene Ther 2001; 8:1011 - 23; http://dx.doi.org/10.1038/sj.gt.3301491; PMID: 11438836
   PubMed Web of Science ®Google Scholar
• Chen Y, Webster RG, Woodland DL. Induction of CD8+ T cell responses to dominant and subdominant epitopes and protective immunity to Sendai virus infection by DNA vaccination. J Immunol 1998; 160:2425 - 32; PMID: 9498786
   PubMed Web of Science ®Google Scholar
• Chulay JD, Schneider I, Cosgriff TM, Hoffman SL, Ballou WR, Quakyi IA, et al. Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. Am J Trop Med Hyg 1986; 35:66 - 8; PMID: 3511753
   PubMed Web of Science ®Google Scholar
• Sinden RE. A biologist’s perspective on malaria vaccine development. Hum Vaccin 2010; 6:3 - 11; http://dx.doi.org/10.4161/hv.6.1.9604; PMID: 19946205
   PubMed Web of Science ®Google Scholar
• Khusmith S, Charoenvit Y, Kumar S, Sedegah M, Beaudoin RL, Hoffman SL. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 1991; 252:715 - 8; http://dx.doi.org/10.1126/science.1827210; PMID: 1827210
   PubMed Web of Science ®Google Scholar
• Baer K, Klotz C, Kappe SH, Schnieder T, Frevert U. Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog 2007; 3:e171; http://dx.doi.org/10.1371/journal.ppat.0030171; PMID: 17997605
   PubMed Web of Science ®Google Scholar
• Jiang G, Charoenvit Y, Moreno A, Baraceros MF, Banania G, Richie N, et al. Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization. Malar J 2007; 6:135; http://dx.doi.org/10.1186/1475-2875-6-135; PMID: 17925026
   PubMed Web of Science ®Google Scholar
• Jiang G, Shi M, Conteh S, Richie N, Banania G, Geneshan H, et al. Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies. PLoS ONE 2009; 4:e6559; http://dx.doi.org/10.1371/journal.pone.0006559; PMID: 19668343
   PubMed Web of Science ®Google Scholar
• Collins WE, Contacos PG, Jumper JR, Smith CS, Skinner JC. Studies on the exoerythrocytic stages of simian malaria. 8. Plasmodium knowlesi. J Parasitol 1973; 59:344 - 52; http://dx.doi.org/10.2307/3278832; PMID: 4633177
   PubMed Web of Science ®Google Scholar
• Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. J Exp Med 1996; 183:1739 - 46; http://dx.doi.org/10.1084/jem.183.4.1739; PMID: 8666931
   PubMed Web of Science ®Google Scholar
• Hedstrom RC, Doolan DL, Wang R, Kumar A, Sacci JB Jr., Gardner MJ, et al. In vitro expression and in vivo immunogenicity of Plasmodium falciparum pre-erythrocytic stage DNA vaccines. Int J Mol Med 1998; 2:29 - 38; PMID: 9854139
   PubMed Web of Science ®Google Scholar
• Sedegah M, Charoenvit Y, Minh L, Belmonte M, Majam VF, Abot S, et al. Reduced immunogenicity of DNA vaccine plasmids in mixtures. Gene Ther 2004; 11:448 - 56; http://dx.doi.org/10.1038/sj.gt.3302139; PMID: 14973538
   PubMed Web of Science ®Google Scholar
• Bacon DJ, Sedegah M. Reduced production of RNA transcripts from individual DNA plasmids given in a multivalent DNA vaccine formula. Hum Vaccin 2007; 3:48 - 53; http://dx.doi.org/10.4161/hv.3.2.3833; PMID: 17312401
   PubMed Web of Science ®Google Scholar
• Robertson JS. Safety considerations for nucleic acid vaccines. Vaccine 1994; 12:1526 - 8; http://dx.doi.org/10.1016/0264-410X(94)90077-9; PMID: 7879418
   PubMed Web of Science ®Google Scholar
• Chen TT, Levy R. Induction of autoantibody responses to GM-CSF by hyperimmunization with an Id-GM-CSF fusion protein. J Immunol 1995; 154:3105 - 17; PMID: 7897201
   PubMed Web of Science ®Google Scholar
• Clarkson PM, Kearns AK, Rouzier P, Rubin R, Thompson PD. Serum creatine kinase levels and renal function measures in exertional muscle damage. Med Sci Sports Exerc 2006; 38:623 - 7; http://dx.doi.org/10.1249/01.mss.0000210192.49210.fc; PMID: 16679975
   PubMed Web of Science ®Google Scholar
• Kenney K, Landau ME, Gonzalez RS, Hundertmark J, O’Brien K, Campbell WW. Serum creatine kinase after exercise: drawing the line between physiological response and exertional rhabdomyolysis. Muscle Nerve 2012; 45:356 - 62; http://dx.doi.org/10.1002/mus.22317; PMID: 22334169
   PubMed Web of Science ®Google Scholar
• Gilbert SC, Moorthy VS, Andrews L, Pathan AA, McConkey SJ, Vuola JM, et al. Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis. Vaccine 2006; 24:4554 - 61; http://dx.doi.org/10.1016/j.vaccine.2005.08.048; PMID: 16150517
   PubMed Web of Science ®Google Scholar
• Gorse GJ, Newman MJ, deCamp A, Hay CM, De Rosa SC, Noonan E, et al, NIAID HIV Vaccine Trials Network. DNA and modified vaccinia virus Ankara vaccines encoding multiple cytotoxic and helper T-lymphocyte epitopes of human immunodeficiency virus type 1 (HIV-1) are safe but weakly immunogenic in HIV-1-uninfected, vaccinia virus-naive adults. Clin Vaccine Immunol 2012; 19:649 - 58; http://dx.doi.org/10.1128/CVI.00038-12; PMID: 22398243
   PubMed Web of Science ®Google Scholar
• Narum DL, Kumar S, Rogers WO, Fuhrmann SR, Liang H, Oakley M, et al. Codon optimization of gene fragments encoding Plasmodium falciparum merozoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. Infect Immun 2001; 69:7250 - 3; http://dx.doi.org/10.1128/IAI.69.12.7250-7253.2001; PMID: 11705894
   PubMed Web of Science ®Google Scholar
• Vasan S, Hurley A, Schlesinger SJ, Hannaman D, Gardiner DF, Dugin DP, et al. In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers. PLoS ONE 2011; 6:e19252; http://dx.doi.org/10.1371/journal.pone.0019252; PMID: 21603651
   PubMed Web of Science ®Google Scholar
• Sedegah M, Weiss W, Sacci JB Jr., Charoenvit Y, Hedstrom R, Gowda K, et al. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus. J Immunol 2000; 164:5905 - 12; PMID: 10820272
   PubMed Web of Science ®Google Scholar
• Kumaratilake LM, Ferrante A, Jaeger T, Rzepczyk C. GM-CSF-induced priming of human neutrophils for enhanced phagocytosis and killing of asexual blood stages of Plasmodium falciparum: synergistic effects of GM-CSF and TNF. Parasite Immunol 1996; 18:115 - 23; http://dx.doi.org/10.1046/j.1365-3024.1996.d01-64.x; PMID: 9223165
   PubMed Web of Science ®Google Scholar
• Singh PP, Singh S. Protection of mice from malaria after co-administration of recombinant mouse granulocyte-macrophage colony- stimulating factor and methionine-enkephalin. Eur Cytokine Netw 2001; 12:528 - 36; PMID: 11566634
   PubMed Web of Science ®Google Scholar
• Schneider J, Langermans JA, Gilbert SC, Blanchard TJ, Twigg S, Naitza S, et al. A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees. Vaccine 2001; 19:4595 - 602; http://dx.doi.org/10.1016/S0264-410X(01)00260-2; PMID: 11535306
   PubMed Web of Science ®Google Scholar
• Haddad D, Ramprakash J, Sedegah M, Charoenvit Y, Baumgartner R, Kumar S, et al. Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles. J Immunol 2000; 165:3772 - 81; PMID: 11034382
   PubMed Web of Science ®Google Scholar
• Sedegah M, Brice GT, Rogers WO, Doolan DL, Charoenvit Y, Jones TR, et al. Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations. Infect Immun 2002; 70:3493 - 9; http://dx.doi.org/10.1128/IAI.70.7.3493-3499.2002; PMID: 12065488
   PubMed Web of Science ®Google Scholar
• Sedegah M, Belmonte M, Epstein JE, Siegrist CA, Weiss WR, Jones TR, et al. Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothers. J Immunol 2003; 171:3148 - 53; PMID: 12960342
   PubMed Web of Science ®Google Scholar
• Kumar S, Miller LH, Quakyi IA, Keister DB, Houghten RA, Maloy WL, et al. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature 1988; 334:258 - 60; http://dx.doi.org/10.1038/334258a0; PMID: 2456467
   PubMed Web of Science ®Google Scholar
• Sakai T, Horii T, Hisaeda H, Zhang M, Ishii K, Nakano Y, et al. DNA immunization with Plasmodium falciparum serine repeat antigen: regulation of humoral immune response by coinoculation of cytokine expression plasmid. Parasitol Int 1999; 48:27 - 33; http://dx.doi.org/10.1016/S1383-5769(98)00036-1; PMID: 11269323
   PubMedGoogle Scholar
• Sanchez GI, Sedegah M, Rogers WO, Jones TR, Sacci J, Witney A, et al. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice. Infect Immun 2001; 69:3897 - 905; http://dx.doi.org/10.1128/IAI.69.6.3897-3905.2001; PMID: 11349057
   PubMed Web of Science ®Google Scholar
• Li N, Yu YZ, Yu WY, Sun ZW. Enhancement of the immunogenicity of DNA replicon vaccine of Clostridium botulinum neurotoxin serotype A by GM-CSF gene adjuvant. Immunopharmacol Immunotoxicol 2011; 33:211 - 9; http://dx.doi.org/10.3109/08923971003782327; PMID: 21284488
   PubMed Web of Science ®Google Scholar
• Bråve A, Ljungberg K, Boberg A, Rollman E, Isaguliants M, Lundgren B, et al. Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery. Mol Ther 2005; 12:1197 - 205; http://dx.doi.org/10.1016/j.ymthe.2005.06.473; PMID: 16112909
   PubMed Web of Science ®Google Scholar
• Lai L, Kwa S, Kozlowski PA, Montefiori DC, Ferrari G, Johnson WE, et al. Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine. J Infect Dis 2011; 204:164 - 73; http://dx.doi.org/10.1093/infdis/jir199; PMID: 21628671
   PubMed Web of Science ®Google Scholar
• Sedegah M, Charoenvit Y, Aguiar J, Sacci J, Hedstrom R, Kumar S, et al. Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF. Genes Immun 2004; 5:553 - 61; http://dx.doi.org/10.1038/sj.gene.6364125; PMID: 15318164
   PubMed Web of Science ®Google Scholar
• Rodríguez AM, Pascutti MF, Maeto C, Falivene J, Holgado MP, Turk G, et al. IL-12 and GM-CSF in DNA/MVA immunizations against HIV-1 CRF12_BF Nef induced T-cell responses with an enhanced magnitude, breadth and quality. PLoS ONE 2012; 7:e37801; http://dx.doi.org/10.1371/journal.pone.0037801; PMID: 22655069
   PubMedGoogle Scholar
• Dobaño C, Widera G, Rabussay D, Doolan DL. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation. Vaccine 2007; 25:6635 - 45; http://dx.doi.org/10.1016/j.vaccine.2007.06.036; PMID: 17669562
   PubMed Web of Science ®Google Scholar
• Wunderlich G, Moura IC, del Portillo HA. Genetic immunization of BALB/c mice with a plasmid bearing the gene coding for a hybrid merozoite surface protein 1-hepatitis B virus surface protein fusion protects mice against lethal Plasmodium chabaudi chabaudi PC1 infection. Infect Immun 2000; 68:5839 - 45; http://dx.doi.org/10.1128/IAI.68.10.5839-5845.2000; PMID: 10992493
   PubMed Web of Science ®Google Scholar
• Cassaday RD, Sondel PM, King DM, Macklin MD, Gan J, Warner TF, et al. A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients. Clin Cancer Res 2007; 13:540 - 9; http://dx.doi.org/10.1158/1078-0432.CCR-06-2039; PMID: 17255276
   PubMed Web of Science ®Google Scholar
• Perales MA, Yuan J, Powel S, Gallardo HF, Rasalan TS, Gonzalez C, et al. Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma. Mol Ther 2008; 16:2022 - 9; http://dx.doi.org/10.1038/mt.2008.196; PMID: 18797450
   PubMed Web of Science ®Google Scholar
• Senzer N, Barve M, Kuhn J, Melnyk A, Beitsch P, Lazar M, et al. Phase I trial of “bi-shRNAi(furin)/GMCSF DNA/autologous tumor cell” vaccine (FANG) in advanced cancer. Mol Ther 2012; 20:679 - 86; http://dx.doi.org/10.1038/mt.2011.269; PMID: 22186789
   PubMed Web of Science ®Google Scholar
• Kumar S, Villinger F, Oakley M, Aguiar JC, Jones TR, Hedstrom RC, et al. A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony stimulating factor. Immunol Lett 2002; 81:13 - 24; http://dx.doi.org/10.1016/S0165-2478(01)00316-9; PMID: 11841841
   PubMed Web of Science ®Google Scholar
• Kusakabe K, Xin KQ, Katoh H, Sumino K, Hagiwara E, Kawamoto S, et al. The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine. J Immunol 2000; 164:3102 - 11; PMID: 10706700
   PubMed Web of Science ®Google Scholar
• Kraynyak KA, Kutzler MA, Cisper NJ, Laddy DJ, Morrow MP, Waldmann TA, et al. Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo. Hum Gene Ther 2009; 20:1143 - 56; http://dx.doi.org/10.1089/hum.2009.025; PMID: 19530914
   PubMed Web of Science ®Google Scholar
• Ramanathan MP, Kutzler MA, Kuo YC, Yan J, Liu H, Shah V, et al. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII. Vaccine 2009; 27:4370 - 80; http://dx.doi.org/10.1016/j.vaccine.2009.01.137; PMID: 19497647
   PubMed Web of Science ®Google Scholar
• Morrow MP, Pankhong P, Laddy DJ, Schoenly KA, Yan J, Cisper N, et al. Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. Blood 2009; 113:5868 - 77; http://dx.doi.org/10.1182/blood-2008-11-190520; PMID: 19304955
   PubMed Web of Science ®Google Scholar
• Muthumani G, Laddy DJ, Sundaram SG, Fagone P, Shedlock DJ, Kannan S, et al. Co-immunization with an optimized plasmid-encoded immune stimulatory interleukin, high-mobility group box 1 protein, results in enhanced interferon-gamma secretion by antigen-specific CD8 T cells. Immunology 2009; 128:Suppl e612 - 20; http://dx.doi.org/10.1111/j.1365-2567.2009.03044.x; PMID: 19740322
   PubMed Web of Science ®Google Scholar
• Belisle SE, Yin J, Shedlock DJ, Dai A, Yan J, Hirao L, et al. Long-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine. PLoS ONE 2011; 6:e19681; http://dx.doi.org/10.1371/journal.pone.0019681; PMID: 21701683
   PubMedGoogle Scholar
• Yin J, Dai A, Lecureux J, Arango T, Kutzler MA, Yan J, et al. High antibody and cellular responses induced to HIV-1 clade C envelope following DNA vaccines delivered by electroporation. Vaccine 2011; 29:6763 - 70; http://dx.doi.org/10.1016/j.vaccine.2010.12.055; PMID: 21195801
   PubMed Web of Science ®Google Scholar
• Institute NC. Common Toxicity Criteria Version 2.0. In: http://ctepcancergov/protocolDevelopment/electronic_applications/ctchtm; 1999.
   Google Scholar
• Rickman LS, Jones TR, Long GW, Paparello S, Schneider I, Paul CF, et al. Plasmodium falciparum-infected Anopheles stephensi inconsistently transmit malaria to humans. Am J Trop Med Hyg 1990; 43:441 - 5; PMID: 2240371
   PubMed Web of Science ®Google Scholar
• Wang R, Epstein J, Baraceros FM, Gorak EJ, Charoenvit Y, Carucci DJ, et al. Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci USA 2001; 98:10817 - 22; http://dx.doi.org/10.1073/pnas.181123498; PMID: 11526203
   PubMed Web of Science ®Google Scholar
• Aguiar JC, Hedstrom RC, Rogers WO, Charoenvit Y, Sacci JB Jr., Lanar DE, et al. Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device. Vaccine 2001; 20:275 - 80; http://dx.doi.org/10.1016/S0264-410X(01)00273-0; PMID: 11567774
   PubMed Web of Science ®Google Scholar
• Szarfman A, Lyon JA, Walliker D, Quakyi I, Howard RJ, Sun S, et al. Mature liver stages of cloned Plasmodium falciparum share epitopes with proteins from sporozoites and asexual blood stages. Parasite Immunol 1988; 10:339 - 51; http://dx.doi.org/10.1111/j.1365-3024.1988.tb00225.x; PMID: 2457864
   PubMed Web of Science ®Google Scholar
• Charoenvit Y, Majam VF, Corradin G, Sacci JB Jr., Wang R, Doolan DL, et al. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Infect Immun 1999; 67:5604 - 14; PMID: 10531206
   PubMed Web of Science ®Google Scholar
• Dodoo D, Hollingdale MR, Anum D, Koram KA, Gyan B, Akanmori BD, et al. Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults. Malar J 2011; 10:168; http://dx.doi.org/10.1186/1475-2875-10-168; PMID: 21689436
   PubMed Web of Science ®Google Scholar
• Doolan DL, Wizel B, Hoffman SL. Class I HLA-restricted cytotoxic T lymphocyte responses against malaria--elucidation on the basis of HLA peptide binding motifs. Immunol Res 1996; 15:280 - 305; http://dx.doi.org/10.1007/BF02935313; PMID: 8988396
   PubMed Web of Science ®Google Scholar
• Weiss WR, Jiang CG. Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. PLoS ONE 2012; 7:e31247; http://dx.doi.org/10.1371/journal.pone.0031247; PMID: 22355349
   PubMed Web of Science ®Google Scholar